Anna Jacobs

Company: BARDA

Job title: Biologist

Seminars:

Spearheading the Investment Opportunities for Bacteriophage Therapies to Become the Standard of Care in Antibiotic Resistant Infections 1:00 pm

Investment and funding is vital to secure for bacteriophage companies to develop effective therapies and proceed to the clinic for randomized, pivotal clinical trials. Demonstrating the untapped potential of bacteriophages to treat antibiotic-resistant infections and beyond to investors is a necessary step on the path to replacing antibiotics as the standard of care. Join us…Read more

day: Pre-Conference Workshop Day